Radnet Inc · Q3 2023 earnings

Briefing

RadNet reported strong procedural volumes, contributing to the highest third quarter revenue in the company's history, with significant growth in the AI segment and expansion of the Cedars-Sinai partnership.

RadNet reported a strong third quarter in 2023, achieving record revenue and increased Adjusted EBITDA. The company saw growth in both its Imaging Center and AI segments, and expanded its partnership with Cedars-Sinai. RadNet also increased its 2023 guidance range for Adjusted EBITDA for the third time this year.

• Imaging Center segment Revenue increased 14.3%, driven by 8.6% aggregate and 4.2% same center procedural volume growth.
• Imaging Center segment Adjusted EBITDA increased 20.3% as compared with last year’s third quarter, resulting in Imaging Center margin expansion from 14.4% to 15.1%.
• AI segment revenue increased by 221% from last year’s third quarter, driven by the launch of the Enhanced Breast Cancer Detection (EBCD) mammography offering.
• Expanded outpatient radiology partnership with Cedars-Sinai, establishing a new joint venture and broadening an existing one, increasing patient access to outpatient radiology.

Headline financials

Revenue & EPS history

RadNet increased its guidance level for Adjusted EBITDA to reflect continued strong operating performance, driven by strong procedural volumes, revenue, and improved margins through active expense management. The company also raised its capital expenditure guidance range to account for reinvestment of cash flow into expanding capacity, de novo facilities, hospital joint ventures and information technology solutions.